212
Views
28
CrossRef citations to date
0
Altmetric
Research Articles

Plasma YKL-40 in relation to the degree of coronary artery disease in patients with stable ischemic heart disease

, , , , , , & show all
Pages 439-447 | Received 16 Jan 2011, Accepted 26 Apr 2011, Published online: 10 Aug 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Ture Lange Nielsen, Louis Lind Plesner, Peder Emil Warming, Jannik Langtved Pallisgaard, Morten Dalsgaard, Morten Schou, Ulla Høst, Casper Rydahl, Lisbet Brandi, Lars Køber, Julia Sidenius Johansen, Jens Kastrup & Kasper Karmark Iversen. (2018) YKL-40 in patients with end-stage renal disease receiving haemodialysis. Biomarkers 23:4, pages 357-363.
Read now
A. D. Kjaergaard, J. S. Johansen, S. E. Bojesen & B. G. Nordestgaard. (2016) Role of inflammatory marker YKL-40 in the diagnosis, prognosis and cause of cardiovascular and liver diseases. Critical Reviews in Clinical Laboratory Sciences 53:6, pages 396-408.
Read now

Articles from other publishers (26)

Yingjian Deng, Guiyang Li, Dong Chang & Xin Su. (2020) YKL-40 as a novel biomarker in cardio-metabolic disorders and inflammatory diseases. Clinica Chimica Acta 511, pages 40-46.
Crossref
Yoowon Kwon, Ju Hee Kim, Eun Kyo Ha, Hye Mi Jee, Hey Sung Baek, Man Yong Han & Su Jin Jeong. (2020) Serum YKL-40 Levels Are Associated with the Atherogenic Index of Plasma in Children. Mediators of Inflammation 2020, pages 1-7.
Crossref
Jakob Schroder, Janus Christian Jakobsen, Per Winkel, Jørgen Hilden, Gorm Boje Jensen, Ahmad Sajadieh, Anders Larsson, Johan Ärnlöv, Marina Harutyunyan, Julia S. Johansen, Erik Kjøller, Christian Gluud & Jens Kastrup. (2020) Prognosis and Reclassification by YKL‐40 in Stable Coronary Artery Disease. Journal of the American Heart Association 9:5.
Crossref
In Jun Yeo, Chong-Kil Lee, Sang-Bae Han, Jaesuk Yun & Jin Tae Hong. (2019) Roles of chitinase 3-like 1 in the development of cancer, neurodegenerative diseases, and inflammatory diseases. Pharmacology & Therapeutics 203, pages 107394.
Crossref
Hui Zhang, Wenping Zhou, Chang Cao, Wenjing Zhang, Gangqiong Liu & Jinying Zhang. (2018) Amelioration of atherosclerosis in apolipoprotein E-deficient mice by combined RNA interference of lipoprotein-associated phospholipase A2 and YKL-40. PLOS ONE 13:8, pages e0202797.
Crossref
Cai-Yun Ma, Zhen-Ye Xu, Shao-Ping Wang, Hong-Yu Peng, Fang Liu, Jing-Hua Liu & Feng-Xue Ren. (2018) Change of Inflammatory Factors in Patients with Acute Coronary Syndrome. Chinese Medical Journal 131:12, pages 1444-1449.
Crossref
Alexander Tenenbaum & Enrique Z. Fisman. (2017) Mirroring the CANTOS revolution: is anti-inflammatory therapy for diabetes just around the corner?. Cardiovascular Diabetology 16:1.
Crossref
Yan Jin, Jia-Ning Cao, Chun-Xia Wang, Qiu-Ting Feng, Xin-He Ye, Xin Xu & Cheng-Jian Yang. (2017) High serum YKL-40 level positively correlates with coronary artery disease. Biomarkers in Medicine 11:2, pages 133-139.
Crossref
XiaoYan Long, Hui Hu, Shuyu Li, Mingna Chen, Jizhang Cai & Bingxin Song. (2016) Hippocampal YKL-40 expression in rats after status epilepticus. Epilepsy Research 125, pages 52-57.
Crossref
Doaa S. E. Zaky, Fatma M. Mabrouk, Eman R. Zaki & Olfat M. Hendy. (2016) The value of YKL-40 in ischemic heart disease patients. The Egyptian Journal of Internal Medicine 28:2, pages 71-77.
Crossref
Naja Dam Mygind, Anna Axelsson, Martin H. Ruwald, Morten Dalsgaard, Rolf Steffensen, Kasper Iversen, Julia S. Johansen & Jens Kastrup. (2016) The inflammatory biomarker YKL-40 decreases stepwise after exercise stress test. Cardiovascular Endocrinology 5:1, pages 21-27.
Crossref
Chun-Li Song,   Bin-Li, Hong-Ying Diao, Jiang-Hua Wang, Yong-fei Shi, Yang Lu, Guan Wang, Zi-Yuan Guo, Yang-Xue Li, Jian-Gen Liu, Jin-Peng Wang, Ji-Chang Zhang, Zhuo Zhao, Yi-Hang Liu, Ying Li, Dan Cai & Qian Li. (2016) Diagnostic Value of Serum YKL-40 Level for Coronary Artery Disease: A Meta-Analysis. Journal of Clinical Laboratory Analysis 30:1, pages 23-31.
Crossref
Eva Aguilera, Enric Serra-Planas, M. Luisa Granada, Silvia Pellitero, Jordi L. Reverter, Núria Alonso, Berta Soldevila, Dídac Mauricio & Manel Puig-Domingo. (2015) Relationship of YKL-40 and adiponectin and subclinical atherosclerosis in asymptomatic patients with type 1 diabetes mellitus from a European Mediterranean population. Cardiovascular Diabetology 14:1.
Crossref
Naja Dam Mygind & Jens Kastrup. 2015. General Methods in Biomarker Research and their Applications. General Methods in Biomarker Research and their Applications 783 810 .
Jolanta Malyszko, E. Koc-Zorawska & Jacek Malyszko. (2014) YKL-40, a Marker of Cardiovascular Disease and Endothelial Dysfunction, in Kidney Transplant Recipients. Transplantation Proceedings 46:8, pages 2651-2653.
Crossref
Susanne Elisabeth Hosbond, Axel Cosmus Pyndt Diederichsen, Lotte Saaby, Lars Melholt Rasmussen, Jess Lambrechtsen, Henrik Munkholm, Niels Peter Rønnow Sand, Oke Gerke, Tina Svenstrup Poulsen & Hans Mickley. (2014) Can osteoprotegerin be used to identify the presence and severity of coronary artery disease in different clinical settings?. Atherosclerosis 236:2, pages 230-236.
Crossref
Marina Harutyunyan, Julia S Johansen, Naja D Mygind, Simon B Reuter & Jens Kastrup. (2014) Serum YKL-40 for monitoring myocardial ischemia after revascularization in patients with stable coronary artery disease. Biomarkers in Medicine 8:8, pages 977-988.
Crossref
Zushun Gong, Shanshan Xing, Fei Zheng & Qichong Xing. (2014) Increased Expression of Chitinase 3-Like 1 in Aorta of Patients with Atherosclerosis and Suppression of Atherosclerosis in Apolipoprotein E-Knockout Mice by Chitinase 3-Like 1 Gene Silencing. Mediators of Inflammation 2014, pages 1-12.
Crossref
Naja Dam Mygind & Jens Kastrup. 2014. General Methods in Biomarker Research and their Applications. General Methods in Biomarker Research and their Applications 1 22 .
Sina Adrangi & Mohammad Ali Faramarzi. (2013) From bacteria to human: A journey into the world of chitinases. Biotechnology Advances 31:8, pages 1786-1795.
Crossref
Chih-Hung Lin, Hung-Yuan Li, Yi-Der Jiang, Tien-Jyun Chang & Lee-Ming Chuang. (2013) Plasma YKL-40 predicts 10-year cardiovascular and all-cause mortality in individuals with type 2 diabetes. Clinical Endocrinology 79:2, pages 185-191.
Crossref
Gülay Ulusal Okyay, Ramazan Erdem Er, Merve Yasemin Tekbudak, Özge Paşaoğlu, Salih İnal, Kürşad Öneç, Hatice Paşaoğlu, Kadriye Altok, Ülver Derici & Yasemin Erten. (2013) Novel Inflammatory Marker in Dialysis Patients: YKL-40. Therapeutic Apheresis and Dialysis 17:2, pages 193-201.
Crossref
N. D. Mygind, K. Iversen, L. Køber, J. P. Goetze, H. Nielsen, S. Boesgaard, M. Bay, J. S. Johansen, O. W. Nielsen, V. Kirk & J. Kastrup. (2012) The inflammatory biomarker YKL ‐40 at admission is a strong predictor of overall mortality . Journal of Internal Medicine 273:2, pages 205-216.
Crossref
Hyun Min Kim, Byung-Wan Lee, Young-Mi Song, Won Jin Kim, Hyuk-Jae Chang, Dong-Hoon Choi, Hee Tae Yu, EunSeok Kang, Bong Soo Cha & Hyun Chul Lee. (2012) Potential association between coronary artery disease and the inflammatory biomarker YKL-40 in asymptomatic patients with type 2 diabetes mellitus. Cardiovascular Diabetology 11:1.
Crossref
Marina Harutyunyan, Michael Christiansen, Julia S. Johansen, Lars Køber, Christian Torp-Petersen & Jens Kastrup. (2012) The inflammatory biomarker YKL-40 as a new prognostic marker for all-cause mortality in patients with heart failure. Immunobiology 217:6, pages 652-656.
Crossref
Klaudija Batinic, Clemens Höbaus, Milan Grujicic, Angelika Steffan, Finka Jelic, David Lorant, Thomas Hörtenhuber, Florian Hoellerl, Johanna-Maria Brix, Guntram Schernthaner, Renate Koppensteiner & Gerit-Holger Schernthaner. (2012) YKL-40 is elevated in patients with peripheral arterial disease and diabetes or pre-diabetes. Atherosclerosis 222:2, pages 557-563.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.